| PUBCHEM ID |
72710750
|
| UNII |
6Q3K31AIZE
|
| Preferred Term |
VERTICILLIN G
|
| CAS |
933785-95-6
|
| INCHIKEY |
CVDBEMJTPGTIID-NFIMPBGESA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CC([C@]1(N(C)C2=O)SS[C@]2([C@H](C2([C@@]3([C@H]([C@@]4(C(N(C)C5)=O)SS)O)c(cccc6)c6N[C@@H]3N4C5=O)c(cccc3)c3N[C@H]22)O)N2C1=O)=O
|
| Total Surface Area |
425,01
|
| Relative PSA |
0,47905
|
| TPSA |
277,53
|
| cLogS |
-1,531
|
| MW |
712,851
|
| cLogP |
0,8178
|
| H-Acceptors |
13
|
| H-Donors |
4
|
| Ro5 violations |
2
|
| Druglikeness |
6,0282
|
| DrugScore |
0,113049293065125
|
| Mutagenic |
high
|
| Tumorigenic |
high
|
| Reproductive Effective |
high
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA-
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,6955
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
Low FHMT
|
| Fish Toxicity II |
1,4044
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,5281
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,757
|
| Carcinogenicity (Three-class) |
Non-required
|
